Immunologic biomarkers, morbidity and mortality among HIV patients hospitalised in a Tertiary Care Hospital in the Brazilian Amazon

[1]  M. V. G. de Lacerda,et al.  High Detection Rate of HIV Drug Resistance Mutations among Patients Who Fail Combined Antiretroviral Therapy in Manaus, Brazil , 2021, BioMed research international.

[2]  M. Peluso,et al.  Clinical Outcomes and Immunologic Characteristics of Coronavirus Disease 2019 in People With Human Immunodeficiency Virus , 2020, The Journal of Infectious Diseases.

[3]  J. Chies,et al.  Increased IL-8 levels in HIV-infected individuals who initiated ART with CD4+ T cell counts <350cells/mm3 - A potential hallmark of chronic inflammation. , 2020, Microbes and infection.

[4]  N. M. Véras,et al.  Comparison of cumulative viraemia following treatment initiation with different antiretroviral regimens: a real‐life study in Brazil , 2019, Journal of the International AIDS Society.

[5]  E. Poveda,et al.  Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: a prospective study , 2019, BMC Public Health.

[6]  M. Soares,et al.  Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country? , 2019, AIDS Research and Therapy.

[7]  A. Benzaken,et al.  HIV/AIDS health services in Manaus, Brazil: patient perception of quality and its influence on adherence to antiretroviral treatment , 2019, BMC Health Services Research.

[8]  T. Hallett,et al.  Determinants of survival of people living with HIV/AIDS on antiretroviral therapy in Brazil 2006–2015 , 2019, BMC Infectious Diseases.

[9]  G. John-Stewart,et al.  HIV-exposed uninfected infants: elevated cord blood Interleukin 8 (IL-8) is significantly associated with maternal HIV infection and systemic IL-8 in a Kenyan cohort , 2018, Clinical and Translational Medicine.

[10]  W. Adams,et al.  Spectrum of disease in HIV-positive patients presenting to a tertiary care hospital: a retrospective, cross-sectional review in Kumasi, Ghana , 2018, BMC Infectious Diseases.

[11]  A. Benzaken,et al.  Sociodemographic determinants of attrition in the HIV continuum of care in Brazil, in 2016 , 2018, Medicine.

[12]  D. Havlir,et al.  Biomarkers Associated with Death After Initiating Treatment for Tuberculosis and HIV in Patients with Very Low CD4 Cells , 2018, Pathogens & immunity.

[13]  J. Mallolas,et al.  Full blood count values as a predictor of poor outcome of pneumonia among HIV-infected patients , 2018, BMC Infectious Diseases.

[14]  A. Kritski,et al.  Predictors of mortality among intensive care unit patients coinfected with tuberculosis and HIV , 2018, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[15]  Xiaofang Pei,et al.  Prevalence of Opportunistic Infections and Causes of Death among Hospitalized HIV-Infected Patients in Sichuan, China. , 2018, The Tohoku journal of experimental medicine.

[16]  M. Law,et al.  Socio-economic status and risk of tuberculosis: a case-control study of HIV-infected patients in Asia. , 2018, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[17]  S. Bührer-Sékula,et al.  [Factors associated with TB/HIV coinfection: evidence from notification data in the State of Amazonas, Brazil, 2001-2012]. , 2017, Cadernos de saude publica.

[18]  B. Britigan,et al.  Ga(III) Nanoparticles Inhibit Growth of both Mycobacterium tuberculosis and HIV and Release of Interleukin-6 (IL-6) and IL-8 in Coinfected Macrophages , 2017, Antimicrobial Agents and Chemotherapy.

[19]  T. van der Poll,et al.  Impact of HIV infection on the presentation, outcome and host response in patients admitted to the intensive care unit with sepsis; a case control study , 2016, Critical Care.

[20]  J. Margolick,et al.  Inflammatory Biomarkers and Mortality Risk Among HIV-Suppressed Men: A Multisite Prospective Cohort Study. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  M. Yin,et al.  Plasma IL-6/IL-10 Ratio and IL-8, LDH, and HBDH Level Predict the Severity and the Risk of Death in AIDS Patients with Pneumocystis Pneumonia , 2016, Journal of immunology research.

[22]  S. Kabra,et al.  IL-8 Alterations in HIV-1 Infected Children With Disease Progression , 2016, Medicine.

[23]  H. Ni,et al.  Platelet indices are novel predictors of hospital mortality in intensive care unit patients. , 2014, Journal of critical care.

[24]  A. Ghorpade,et al.  Chemokine CXCL8 Promotes HIV-1 Replication in Human Monocyte-Derived Macrophages and Primary Microglia via Nuclear Factor-κB Pathway , 2014, PloS one.

[25]  Hongxin Zhao,et al.  Spectrums of Opportunistic Infections and Malignancies in HIV-Infected Patients in Tertiary Care Hospital, China , 2013, PloS one.

[26]  S. Lewin,et al.  Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses. , 2013, The Journal of infectious diseases.

[27]  F. Şahin,et al.  Prominent features of platelet count, plateletcrit, mean platelet volume and platelet distribution width in pulmonary tuberculosis , 2012, Multidisciplinary Respiratory Medicine.

[28]  N. Wood,et al.  HIV-associated oral lesions as an indicator for HAART failure: a review. , 2012, SADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging.

[29]  B. Albuquerque,et al.  Factors Associated with Tuberculosis Treatment Default in an Endemic Area of the Brazilian Amazon: A Case Control-Study , 2012, PloS one.

[30]  L. Lindquist,et al.  Risk Factors for Mortality among HIV-Positive Patients with and without Active Tuberculosis in Dar Es Salaam, Tanzania , 2012, Antiviral therapy.

[31]  Handan Wand,et al.  Plasma levels of soluble CD14 independently predict mortality in HIV infection. , 2011, The Journal of infectious diseases.

[32]  Reuben Granich,et al.  HIV infection-associated tuberculosis: the epidemiology and the response. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  C. Obirikorang,et al.  Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting , 2009, Journal of Biomedical Science.

[34]  Elizabeth Moreira dos Santos,et al.  Padrão da infecção pelo HIV/AIDS em Manaus, Estado do Amazonas, no período de 1986 a 2000 , 2009 .

[35]  Irini Sereti,et al.  Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm , 2009, Current opinion in HIV and AIDS.

[36]  A. Phillips,et al.  HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity , 2009, BMJ : British Medical Journal.

[37]  Lewis H Kuller,et al.  Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection , 2008, PLoS medicine.

[38]  V. Appay,et al.  Immune activation and inflammation in HIV‐1 infection: causes and consequences , 2008, The Journal of pathology.

[39]  Felipe García,et al.  Inflammatory Responses in Blood Samples of Human Immunodeficiency Virus-Infected Patients with Pulmonary Infections , 2004, Clinical Diagnostic Laboratory Immunology.

[40]  J. Friedland,et al.  Interleukin-8 Secretion from Mycobacterium tuberculosis-Infected Monocytes Is Regulated by Protein Tyrosine Kinases but Not by ERK1/2 or p38 Mitogen-Activated Protein Kinases , 2002, Infection and Immunity.

[41]  A. Harries,et al.  Moderate to severe malnutrition in patients with tuberculosis is a risk factor associated with early death. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[42]  D. Markovitz,et al.  Interleukin-8 Stimulates Human Immunodeficiency Virus Type 1 Replication and Is a Potential New Target for Antiretroviral Therapy , 2001, Journal of Virology.

[43]  F. Blasi,et al.  Increased Mycobacterium tuberculosis growth in HIV‐1‐infected human macrophages: role of tumour necrosis factor‐α , 2001, Clinical and experimental immunology.

[44]  B. Gesser,et al.  The delayed-type hypersensitivity reaction is dependent on IL-8. Inhibition of a tuberculin skin reaction by an anti-IL-8 monoclonal antibody. , 1995, Journal of immunology.

[45]  R. Lockey,et al.  Elevated serum levels of IL‐8 in patients with HIV infection , 1993, Clinical and experimental immunology.

[46]  A. Benzaken,et al.  HIV/AIDS epidemic in the State of Amazonas: characteristics and trends from 2001 to 2012. , 2015, Revista da Sociedade Brasileira de Medicina Tropical.

[47]  A. Sharma,et al.  Mortality and morbidity patterns among HIV patients with prognostic markers in a tertiary care hospital in southern India. , 2011, The Australasian medical journal.

[48]  E. Gounari,et al.  Platelet distribution width: a simple, practical and specific marker of activation of coagulation. , 2010, Hippokratia.

[49]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..